Targeting survivin (BIRC5) with YM155 for the treatment of head and neck squamous cell carcinoma

被引：0
|
作者：
Kumar, Bhavna [1 ]
Yadav, Arti [1 ]
Teknos, Theodoros N. [1 ]
Kumar, Pawan [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5604
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
    Wang, Hui-Ching
    Chan, Leong-Perng
    Cho, Shih-Feng
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [22] Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma
    Wang, Yu-Fan
    Zhang, Wei
    He, Ke-Fei
    Liu, Bing
    Zhang, Lu
    Zhang, Wen-Feng
    Kulkarni, Ashok B.
    Zhao, Yi-Fang
    Sun, Zhi-Jun
    APOPTOSIS, 2014, 19 (04) : 748 - 758
  • [23] Epigenetic regulation of the Birc5 promoter explains mechanism of action of YM-155 in synovial sarcoma
    Mika, Aleksander
    Luelling, Sarah
    Pavek, Adriene
    Parkinson, Neil
    Heyneman, Alexandra
    Barrott, Jared J.
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma
    L Zhang
    W Zhang
    Y-F Wang
    B Liu
    W-F Zhang
    Y-F Zhao
    A B Kulkarni
    Z-J Sun
    Cell Death & Disease, 2015, 6 : e1771 - e1771
  • [25] Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma
    Zhang, L.
    Zhang, W.
    Wang, Y-F
    Liu, B.
    Zhang, W-F
    Zhao, Y-F
    Kulkarni, A. B.
    Sun, Z-J
    CELL DEATH & DISEASE, 2015, 6 : e1771 - e1771
  • [26] BIRC5 promotes cancer progression and predicts prognosis in laryngeal squamous cell carcinoma
    Wang, Nan
    Huang, Xuanyu
    Cheng, Jinsheng
    PEERJ, 2022, 10
  • [27] Disruption of survivin protein expression by treatment with YM155 accelerates the resolution of neutrophilic inflammation
    Fernandes, Debora de Oliveira
    Machado, Jessica Rayssa
    Beltrami, Vinicius Amorim
    Dos Santos, Anna Clara Paiva Menezes
    Queiroz-Junior, Celso Martins
    Vago, Juliana Priscila
    Soriani, Frederico Marianetti
    Amaral, Flavio Almeida
    Teixeira, Mauro Martins
    Felix, Franciel Batista
    Pinho, Vanessa
    BRITISH JOURNAL OF PHARMACOLOGY, 2025, 182 (05) : 1206 - 1222
  • [28] Potential Clinical Values and Mechanisms of BIRC5 Expression in Lung Squamous Cell Carcinoma
    Li, Guo-Sheng
    He, Rong-Quan
    Li, Lin-Yi
    Yu, Da-Peng
    Li, Cheng-Xin
    He, Wei-Ying
    Yang, Lin-Jie
    Hua-Fu, Zhou
    Kong, Jin-Liang
    Chen, Gang
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1317 - 1318
  • [29] Epigenetic regulation of the Birc5 promoter explains mechanism of action of YM-155 in synovial sarcoma
    Luelling, Sarah
    Mika, Aleksander
    Heyneman, Alexandra
    Parkinson, Neil
    Barrott, Jared
    FASEB JOURNAL, 2019, 33
  • [30] MEDI 312-Discovery of YM155, a novel survivin suppressant for the treatment of cancer
    Kinoyama, Isao
    Matsuhisa, Akira
    Nakahara, Takahito
    Takeuchi, Masahiro
    Shirasuna, Kenna
    Minematsu, Tsuyoshi
    Asai, Norio
    Matsumoto, Shunichiro
    Kawaguchi, Kenichi
    Kazami, Junichi
    Toyoshima, Akira
    Kita, Aya
    Tominaga, Fumiko
    Okada, Minoru
    Ohta, Mitsuaki
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
12345